Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 2,666,702 | 2,158,759 | 1,881,883 | 1,536,216 | 1,105,719 |
| Cost of Goods | 131,328 | 114,249 | 94,123 | 79,479 | 58,187 |
| Gross Profit | 2,535,374 | 2,044,510 | 1,787,760 | 1,456,737 | 1,047,532 |
| Operating Expenses | 2,799,378 | 1,642,753 | 1,658,660 | 1,700,603 | 902,721 |
| Operating Income | -263,676 | 402,006 | 129,223 | -243,387 | 144,998 |
| Interest Expense | 2,174 | 1,855 | 1,543 | 6,900 | 38,745 |
| Other Income | 33,632 | 86,640 | -12,333 | -62,003 | 1,151 |
| Pre-tax Income | -232,218 | 486,791 | 115,347 | -312,290 | 107,404 |
| Income Tax | 63,479 | 39,885 | 5,854 | 852 | 3,182 |
| Net Income Continuous | -295,697 | 446,906 | 109,493 | -313,142 | 104,222 |
| Net Income | $-295,697 | $446,906 | $109,493 | $-313,142 | $104,222 |
| EPS Basic Total Ops | -1.36 | 2.08 | 0.52 | -1.53 | 0.55 |
| EPS Basic Continuous Ops | -1.36 | 2.08 | 0.52 | -1.53 | 0.55 |
| EPS Diluted Total Ops | -1.36 | 2.05 | 0.51 | -1.53 | 0.54 |
| EPS Diluted Continuous Ops | -1.36 | 2.05 | 0.51 | -1.53 | 0.54 |
| EPS Diluted Before Non-Recurring Items | -1.06 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-211,869 | $456,539 | $184,192 | $-191,209 | $203,423 |